1270SP |
Clonazepam and Metabolite, Serum/Plasma |
1958SP |
Estazolam, Serum/Plasma |
1968SP |
Eszopiclone / Zopiclone, Serum/Plasma |
2120SP |
Flurazepam and Metabolites, Serum/Plasma |
2479SP |
Ketamine and Metabolite, Serum/Plasma |
2483SP |
Zolpidem, Serum/Plasma |
2604SP |
Melatonin, Serum/Plasma |
3057SP |
Midazolam, Serum/Plasma |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
4086SP |
Ramelteon and Metabolite, Serum/Plasma |
4236SP |
Suvorexant, Serum/Plasma |
4323SP |
Temazepam and Metabolite, Serum/Plasma |
4543SP |
Triazolam and Metabolite, Serum/Plasma |
4815SP |
Xylazine, Serum/Plasma |
4835SP |
Zaleplon, Serum/Plasma |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9215SP |
Nitrazepam and Metabolite Screen, Serum/Plasma |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |